Not logged in Share Save
Share Save
Temporal Relationship Between Serum Neurofilament Light Chain and Radiologic Disease Activity in Patients With Multiple Sclerosis Fox, Robert J.; Cree, Bruce A. C.; de Seze, Jerome; Gold, Ralf; Hartung, Hans-Peter; Jeffery, Douglas; Kappos, Ludwig; Montalban, Xavier; Weinstock-Guttman, Bianca; Singh, Carol M.; Altincatal, Arman; Belviso, Nicholas; Avila, Robin L.; Ho, Pei-Ran; Su, Ray; Engle, Robert; Sangurdekar, Dipen; de Moor, Carl; Fisher, Elizabeth; Kieseier, Bernd C.; Rudick, Richard A. Share Save
Generating real-world evidence in Alzheimer's disease: Considerations for establishing a core dataset Galvin, James E.; Cummings, Jeffrey L.; Benea, Mihaela Levitchi; de Moor, Carl; Allegri, Ricardo F.; Atri, Alireza; Chertkow, Howard; Paquet, Claire; Porter, Verna R.; Ritchie, Craig W.; Sikkes, Sietske A. M.; Smith, Michael R.; Grassi, Christina Marsica; Rubino, Ivana Share Save
Precision medicine analysis of heterogeneity in individual-level treatment response to amyloid beta removal in early Alzheimer's disease Pang, Menglan; Gabelle, Audrey; Saha-Chaudhuri, Paramita; Huijbers, Willem; Gafson, Arie; Matthews, Paul M.; Tian, Lu; Rubino, Ivana; Hughes, Richard; de Moor, Carl; Belachew, Shibeshih; Shen, Changyu Share Save
Glial fibrillary acidic protein and multiple sclerosis progression independent of acute inflammation Jiang, Xiaotong; Shen, Changyu; Teunissen, Charlotte E.; Wessels, Mark; Zetterberg, Henrik; Giovannoni, Gavin; Singh, Carol M.; Caba, Bastien; Elliott, Colm; Fisher, Elizabeth; de Moor, Carl; Belachew, Shibeshih; Gafson, Arie R. Share Save
Share Save
Toward the end of a controversy on the effect of reduction in brain amyloid levels on change in cognitive and functional decline in Alzheimer's disease-Reply to a letter Pang, Menglan; Zhu, Ling; Gabelle, Audrey; Gafson, Arie R.; Platt, Robert W.; Galvin, James E.; Krolak-Salmon, Pierre; Rubino, Ivana; de Moor, Carl; Belachew, Shibeshih; Shen, Changyu Share Save
Share Save
Effect of reduction in brain amyloid levels on change in cognitive and functional decline in randomized clinical trials: An instrumental variable meta-analysis Pang, Menglan; Zhu, Ling; Gabelle, Audrey; Gafson, Arie R.; Platt, Robert W.; Galvin, James E.; Krolak-Salmon, Pierre; Rubino, Ivana; de Moor, Carl; Belachew, Shibeshih; Shen, Changyu Share Save
Recommendations for the use of propensity score methods in multiple sclerosis research Simoneau, Gabrielle; Pellegrini, Fabio; Debray, Thomas P. A.; Rouette, Julie; Munoz, Johanna; Platt, Robert W.; Petkau, John; Bohn, Justin; Shen, Changyu; de Moor, Carl; Karim, Mohammad Ehsanul Share Save
Measuring treatment response to advance precision medicine for multiple sclerosis Calabresi, Peter A.; Kappos, Ludwig; Giovannoni, Gavin; Plavina, Tatiana; Koulinska, Irene; Edwards, Michael R.; Kieseier, Bernd; de Moor, Carl; Sotirchos, Elias S.; Fisher, Elizabeth; Rudick, Richard A.; Sandrock, Alfred Share Save
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies Reder, Anthony T.; Centonze, Diego; Naylor, Maria L.; Nagpal, Anjali; Rajbhandari, Rajani; Altincatal, Arman; Kim, Michelle; Berdofe, Aaron; Radhakrishnan, Maha; Jung, Eunice; Sandrock, Alfred W.; Smirnakis, Karen; Popescu, Catrinel; de Moor, Carl Share Save
Temporal profile of serum neurofilament light in multiple sclerosis: Implications for patient monitoring Calabresi, Peter A.; Arnold, Douglas L.; Sangurdekar, Dipen; Singh, Carol M.; Altincatal, Arman; de Moor, Carl; Engle, Bob; Goyal, Jaya; Deykin, Aaron; Szak, Suzanne; Kieseier, Bernd C.; Rudick, Richard A.; Plavina, Tatiana Share Save
Share Save
Share Save
Neurofilament light levels are associated with long-term outcomes in multiple sclerosis Kuhle, Jens; Plavina, Tatiana; Barro, Christian; Disanto, Giulio; Sangurdekar, Dipen; Singh, Carol M.; de Moor, Carl; Engle, Bob; Kieseier, Bernd C.; Fisher, Elizabeth; Kappos, Ludwig; Rudick, Richard A.; Goyal, Jaya Share Save
Share Save
Share Save
Share Save